Myriad Genetics, Inc. (MYGN)

Myriad Genetics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	74.4	102.4	132.1	56.9	257.4	117
Short-Term Investments	-	-	8.8	58	81.4	33.7
Cash & Short-Term Investments	74.4	102.4	140.9	114.9	338.8	150.7
Cash Growth	-23.54%	-27.32%	22.63%	-66.09%	124.82%	-30.81%
Accounts Receivable	137	121.2	114.3	101.6	91.3	89.5
Receivables	137	121.2	114.3	101.6	91.3	89.5
Inventory	28.7	27.5	22	20.1	15.3	27.1
Prepaid Expenses	44.2	38.3	35.2	36	39.4	122.1
Restricted Cash	-	8.6	1.2	2	-	-
Total Current Assets	284.3	298	313.6	274.6	484.8	389.4
Property, Plant & Equipment	164.2	172.4	180.6	187.3	125.3	100.4
Long-Term Investments	-	-	-	54.8	59	21
Goodwill	51.6	286.3	287.4	286.8	239.2	329.2
Other Intangible Assets	170.1	265.8	354.1	386.8	410.8	578.8
Other Long-Term Assets	7.1	5.1	10.8	8.4	1.6	-
Total Assets	677.3	1,028	1,147	1,199	1,321	1,419
Accounts Payable	30.9	32.3	25.8	28.8	29.6	20.5
Accrued Expenses	70	79.9	75.7	70.2	82.7	62.1
Current Portion of Leases	9	12.8	16.2	14.1	13	13.6
Current Income Taxes Payable	5.1	5.1	4.6	4.8	4	4.3
Current Unearned Revenue	-	-	-	-	-	32.7
Other Current Liabilities	25.5	34	33.6	19.3	75	12.7
Total Current Liabilities	199.9	164.1	155.9	137.2	204.3	145.9
Long-Term Debt	-	39.6	38.5	-	-	224.8
Long-Term Leases	86.2	87.9	97.4	130.9	79.3	50.6
Long-Term Deferred Tax Liabilities	-	-	-	-	35.8	71.3
Other Long-Term Liabilities	3.1	34.9	71.5	44.8	33.5	45.2
Total Liabilities	289.2	326.5	363.3	312.9	352.9	537.8
Common Stock	0.9	0.9	0.9	0.8	0.8	0.8
Additional Paid-In Capital	1,475	1,458	1,416	1,260	1,226	1,110
Retained Earnings	-1,087	-756.8	-629.5	-366.2	-254.2	-227
Comprehensive Income & Other	-0.1	-0.8	-3.7	-8.9	-5.1	-2.3
Total Common Equity	388.1	701.1	783.2	885.8	967.8	881
Shareholders' Equity	388.1	701.1	783.2	885.8	967.8	881
Total Liabilities & Equity	677.3	1,028	1,147	1,199	1,321	1,419
Total Debt	154.6	140.3	152.1	145	92.3	289
Net Cash (Debt)	-80.2	-37.9	-11.2	24.7	305.5	-117.3
Net Cash Growth	-	-	-	-91.92%	-	-
Net Cash Per Share	-0.88	-0.42	-0.14	0.31	3.92	-1.57
Filing Date Shares Outstanding	93.04	91.31	89.87	81.22	80.02	76.3
Total Common Shares Outstanding	93.1	91.3	89.9	81.2	80	75.4
Working Capital	84.4	133.9	157.7	137.4	280.5	243.5
Book Value Per Share	4.17	7.68	8.71	10.91	12.10	11.68
Tangible Book Value	166.4	149	141.7	212.2	317.8	-27
Tangible Book Value Per Share	1.79	1.63	1.58	2.61	3.97	-0.36
Machinery	113.2	148.5	147.6	124.7	112.4	117.9
Leasehold Improvements	79.2	78.5	91.3	67.9	38	35.7

Updated May 7, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q